Lv5
1160 积分 2026-04-16 加入
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)
2个月前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial
2个月前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
2个月前
已完结
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
2个月前
已完结
Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity
2个月前
已完结
B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis
2个月前
已完结
The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses
2个月前
已完结
Murine B7-H3 Is a Negative Regulator of T Cells
2个月前
已完结
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
2个月前
已完结
皖公网安备34019202002308
